[Use of clofibrate and pyridinol carbamate singly or in combination in the antiarteriosclerotic therapy].
D000328:Adult; D000368:Aged; D001161:Arteriosclerosis / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D002994:Clofibrate / Q000627:therapeutic use*; D004338:Drug Combinations; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011727:Pyridinolcarbamate / Q000627:therapeutic use*
D004338:Drug Combinations; D000960:Hypolipidemic Agents; D011727:Pyridinolcarbamate; D002994:Clofibrate
L'impiego del clofibrato e del piridinolcarbamato, separati ed in associazione, nella terapia antiaterosclerotica